Sign In

Login

Password

Forgot Password ? Sign Up

Włókniakomięsak (Polish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Włókniakomięsak" in Polish language version.

refsWebsite
Global rank Polish rank
38nih.gov
4th place
7th place
23doi.org
2nd place
6th place
2google.pl
low place
557th place
1ascopubs.org
low place
8,458th place
1annalsofoncology.org
low place
low place
1hindawi.com
6,828th place
4,329th place

annalsofoncology.org

ascopubs.org

jco.ascopubs.org

doi.org

  • S. Furudate, T. Fujimura, Y. Kambayashi, A. Tsukada i inni. Multiple low-grade fibromyxoid sarcoma on the upper arms with atypical histological presentation. „Case Rep Dermatol”. 5 (2), s. 152–155, May 2013. DOI: 10.1159/000351791. PMID: 23741216. 
  • A. Bahrami, A.L. Folpe. Adult-type fibrosarcoma: A reevaluation of 163 putative cases diagnosed at a single institution over a 48-year period. „Am J Surg Pathol”. 34 (10), s. 1504–1513, Oct 2010. DOI: 10.1097/PAS.0b013e3181ef70b6. PMID: 20829680. 
  • Z. Burningham, M. Hashibe, L. Spector, J.D. Schiffman. The epidemiology of sarcoma. „Clin Sarcoma Res”. 2 (1), s. 14, 2012. DOI: 10.1186/2045-3329-2-14. PMID: 23036164. 
  • D. Orbach, A. Rey, G. Cecchetto, O. Oberlin i inni. Infantile fibrosarcoma: management based on the European experience. „J Clin Oncol”. 28 (2), s. 318–323, Jan 2010. DOI: 10.1200/JCO.2009.21.9972. PMID: 19917847. 
  • H.L. Evans. Low-grade fibromyxoid sarcoma: a clinicopathologic study of 33 cases with long-term follow-up. „Am J Surg Pathol”. 35 (10), s. 1450–1462, Oct 2011. DOI: 10.1097/PAS.0b013e31822b3687. PMID: 21921785. 
  • T.G. Grunewald, I. von Luettichau, G. Weirich, A. Wawer i inni. Sclerosing epithelioid fibrosarcoma of the bone: a case report of high resistance to chemotherapy and a survey of the literature. „Sarcoma”. 2010, s. 431627, 2010. DOI: 10.1155/2010/431627. PMID: 20396630. 
  • C. Prieto-Granada, L. Zhang, H.W. Chen, Y.S. Sung i inni. A genetic dichotomy between pure sclerosing epithelioid fibrosarcoma (SEF) and hybrid SEF/low-grade fibromyxoid sarcoma: a pathologic and molecular study of 18 cases. „Genes Chromosomes Cancer”. 54 (1), s. 28–38, Jan 2015. DOI: 10.1002/gcc.22215. PMID: 25231134. 
  • C. Ossendorf, G.M. Studer, B. Bode, B. Fuchs. Sclerosing epithelioid fibrosarcoma: case presentation and a systematic review. „Clin Orthop Relat Res”. 466 (6), s. 1485–1491, Jun 2008. DOI: 10.1007/s11999-008-0205-8. PMID: 18340502. 
  • P.G. Casali, J.Y. Blay, A. Bertuzzi, S. Bielack i inni. Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. „Ann Oncol”. 25 Suppl 3, s. iii102-12, Sep 2014. DOI: 10.1093/annonc/mdu254. PMID: 25210080. 
  • R. Grimer, I. Judson, D. Peake, B. Seddon. Guidelines for the management of soft tissue sarcomas. „Sarcoma”. 2010, s. 506182, 2010. DOI: 10.1155/2010/506182. PMID: 20634933. 
  • H.A. Domanski. Fine-needle aspiration cytology of soft tissue lesions: diagnostic challenges. „Diagn Cytopathol”. 35 (12), s. 768–773, Dec 2007. DOI: 10.1002/dc.20765. PMID: 18008345. 
  • B.P. Rubin, C.J. Chen, T.W. Morgan, S. Xiao i inni. Congenital mesoblastic nephroma t(12;15) is associated with ETV6-NTRK3 gene fusion: cytogenetic and molecular relationship to congenital (infantile) fibrosarcoma. „Am J Pathol”. 153 (5), s. 1451–1458, Nov 1998. DOI: 10.1016/S0002-9440(10)65732-X. PMID: 9811336. 
  • I. Panagopoulos, C.T. Storlazzi, C.D. Fletcher, J.A. Fletcher i inni. The chimeric FUS/CREB3l2 gene is specific for low-grade fibromyxoid sarcoma. „Genes Chromosomes Cancer”. 40 (3), s. 218–228, Jul 2004. DOI: 10.1002/gcc.20037. PMID: 15139001. 
  • A. Matsuyama, M. Hisaoka, S. Shimajiri, T. Hayashi i inni. Molecular detection of FUS-CREB3L2 fusion transcripts in low-grade fibromyxoid sarcoma using formalin-fixed, paraffin-embedded tissue specimens. „Am J Surg Pathol”. 30 (9), s. 1077–1084, Sep 2006. DOI: 10.1097/01.pas.0000209830.24230.1f. PMID: 16931951. 
  • L. Guillou, J. Benhattar, C. Gengler, G. Gallagher i inni. Translocation-positive low-grade fibromyxoid sarcoma: clinicopathologic and molecular analysis of a series expanding the morphologic spectrum and suggesting potential relationship to sclerosing epithelioid fibrosarcoma: a study from the French Sarcoma Group. „Am J Surg Pathol”. 31 (9), s. 1387–1402, Sep 2007. DOI: 10.1097/PAS.0b013e3180321959. PMID: 17721195. 
  • S. Indap, M. Dasgupta, N. Chakrabarti, A. Agarwal. Low grade fibromyxoid sarcoma (Evans tumour) of the arm. „Indian J Plast Surg”. 47 (2), s. 259–262, May 2014. DOI: 10.4103/0970-0358.138973. PMID: 25190926. 
  • A. Kanno, M. Hatori, M. Hosaka, K.N. Kishimoto i inni. Multiple bone metastasis of sclerosing epithelioid fibrosarcoma 12 years after initial surgery-increasing ki-67 labeling index. „Sarcoma”. 2009, s. 953750, 2009. DOI: 10.1155/2009/953750. PMID: 19343182. 
  • H. Russell, M.J. Hicks, A.A. Bertuch, M. Chintagumpala. Infantile fibrosarcoma: clinical and histologic responses to cytotoxic chemotherapy. „Pediatr Blood Cancer”. 53 (1), s. 23–27, Jul 2009. DOI: 10.1002/pbc.21981. PMID: 19340853. 
  • W.S. Ferguson. Advances in the adjuvant treatment of infantile fibrosarcoma. „Expert Rev Anticancer Ther”. 3 (2), s. 185–191, Apr 2003. DOI: 10.1586/14737140.3.2.185. PMID: 12722878. 
  • Q. Bao, H. Niess, R. Djafarzadeh, Y. Zhao i inni. Recombinant TIMP-1-GPI inhibits growth of fibrosarcoma and enhances tumor sensitivity to doxorubicin. „Target Oncol”. 9 (3), s. 251–261, Sep 2014. DOI: 10.1007/s11523-013-0294-5. PMID: 23934106. 
  • M. Lehnhardt, L. Klein-Hitpass, C. Kuhnen, H.H. Homann i inni. Response rate of fibrosarcoma cells to cytotoxic drugs on the expression level correlates to the therapeutic response rate of fibrosarcomas and is mediated by regulation of apoptotic pathways. „BMC Cancer”. 5, s. 74, 2005. DOI: 10.1186/1471-2407-5-74. PMID: 16001973. 
  • V.H. Bramwell, D. Anderson, M.L. Charette. Doxorubicin-based chemotherapy for the palliative treatment of adult patients with locally advanced or metastatic soft tissue sarcoma. „Cochrane Database Syst Rev”, s. CD003293, 2003. DOI: 10.1002/14651858.CD003293. PMID: 12917960. 
  • V. Dewan, A. Darbyshire, V. Sumathi, L. Jeys i inni. Prognostic and survival factors in myxofibrosarcomas. „Sarcoma”. 2012, s. 830879, 2012. DOI: 10.1155/2012/830879. PMID: 22736953. 

google.pl

books.google.pl

hindawi.com

nih.gov

ncbi.nlm.nih.gov

  • S. Furudate, T. Fujimura, Y. Kambayashi, A. Tsukada i inni. Multiple low-grade fibromyxoid sarcoma on the upper arms with atypical histological presentation. „Case Rep Dermatol”. 5 (2), s. 152–155, May 2013. DOI: 10.1159/000351791. PMID: 23741216. 
  • A. Bahrami, A.L. Folpe. Adult-type fibrosarcoma: A reevaluation of 163 putative cases diagnosed at a single institution over a 48-year period. „Am J Surg Pathol”. 34 (10), s. 1504–1513, Oct 2010. DOI: 10.1097/PAS.0b013e3181ef70b6. PMID: 20829680. 
  • Z. Burningham, M. Hashibe, L. Spector, J.D. Schiffman. The epidemiology of sarcoma. „Clin Sarcoma Res”. 2 (1), s. 14, 2012. DOI: 10.1186/2045-3329-2-14. PMID: 23036164. 
  • D. Harms. New entities, concepts, and questions in childhood tumor pathology. „Gen Diagn Pathol”. 141 (1), s. 1–14, May 1995. PMID: 8542501. 
  • D. Orbach, A. Rey, G. Cecchetto, O. Oberlin i inni. Infantile fibrosarcoma: management based on the European experience. „J Clin Oncol”. 28 (2), s. 318–323, Jan 2010. DOI: 10.1200/JCO.2009.21.9972. PMID: 19917847. 
  • A.L. Folpe, K.L. Lane, G. Paull, S.W. Weiss. Low-grade fibromyxoid sarcoma and hyalinizing spindle cell tumor with giant rosettes: a clinicopathologic study of 73 cases supporting their identity and assessing the impact of high-grade areas. „Am J Surg Pathol”. 24 (10), s. 1353–1360, Oct 2000. PMID: 11023096. 
  • J.M. Meis-Kindblom, L.G. Kindblom, F.M. Enzinger. Sclerosing epithelioid fibrosarcoma. A variant of fibrosarcoma simulating carcinoma. „Am J Surg Pathol”. 19 (9), s. 979–993, Sep 1995. PMID: 7661286. 
  • H.L. Evans. Low-grade fibromyxoid sarcoma: a clinicopathologic study of 33 cases with long-term follow-up. „Am J Surg Pathol”. 35 (10), s. 1450–1462, Oct 2011. DOI: 10.1097/PAS.0b013e31822b3687. PMID: 21921785. 
  • T.G. Grunewald, I. von Luettichau, G. Weirich, A. Wawer i inni. Sclerosing epithelioid fibrosarcoma of the bone: a case report of high resistance to chemotherapy and a survey of the literature. „Sarcoma”. 2010, s. 431627, 2010. DOI: 10.1155/2010/431627. PMID: 20396630. 
  • C.R. Antonescu, M.K. Rosenblum, P. Pereira, A.G. Nascimento i inni. Sclerosing epithelioid fibrosarcoma: a study of 16 cases and confirmation of a clinicopathologically distinct tumor. „Am J Surg Pathol”. 25 (6), s. 699–709, Jun 2001. PMID: 11395547. 
  • C. Prieto-Granada, L. Zhang, H.W. Chen, Y.S. Sung i inni. A genetic dichotomy between pure sclerosing epithelioid fibrosarcoma (SEF) and hybrid SEF/low-grade fibromyxoid sarcoma: a pathologic and molecular study of 18 cases. „Genes Chromosomes Cancer”. 54 (1), s. 28–38, Jan 2015. DOI: 10.1002/gcc.22215. PMID: 25231134. 
  • C. Ossendorf, G.M. Studer, B. Bode, B. Fuchs. Sclerosing epithelioid fibrosarcoma: case presentation and a systematic review. „Clin Orthop Relat Res”. 466 (6), s. 1485–1491, Jun 2008. DOI: 10.1007/s11999-008-0205-8. PMID: 18340502. 
  • P.G. Casali, J.Y. Blay, A. Bertuzzi, S. Bielack i inni. Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. „Ann Oncol”. 25 Suppl 3, s. iii102-12, Sep 2014. DOI: 10.1093/annonc/mdu254. PMID: 25210080. 
  • R. Grimer, I. Judson, D. Peake, B. Seddon. Guidelines for the management of soft tissue sarcomas. „Sarcoma”. 2010, s. 506182, 2010. DOI: 10.1155/2010/506182. PMID: 20634933. 
  • H.A. Domanski. Fine-needle aspiration cytology of soft tissue lesions: diagnostic challenges. „Diagn Cytopathol”. 35 (12), s. 768–773, Dec 2007. DOI: 10.1002/dc.20765. PMID: 18008345. 
  • M. von Mehren, R.L. Randall, R.S. Benjamin, S. Boles i inni. Soft tissue sarcoma, version 2.2014. „J Natl Compr Canc Netw”. 12 (4), s. 473–483, Apr 2014. PMID: 24717567. 
  • M. von Mehren, R.S. Benjamin, M.M. Bui, E.U. Conrad. Soft tissue sarcoma, version 1.2015. „National Comprehensive Cancer Network”. PMID: 22878820. 
  • J.D. Pfeifer, D.A. Hill, M.J. O’Sullivan, L.P. Dehner. Diagnostic gold standard for soft tissue tumours: morphology or molecular genetics?. „Histopathology”. 37 (6), s. 485–500, Dec 2000. PMID: 11122430. 
  • J. Limon, A. Szadowska, M. Iliszko, M. Babińska i inni. Recurrent chromosome changes in two adult fibrosarcomas. „Genes Chromosomes Cancer”. 21 (2), s. 119–123, Feb 1998. PMID: 9491323. 
  • B.P. Rubin, C.J. Chen, T.W. Morgan, S. Xiao i inni. Congenital mesoblastic nephroma t(12;15) is associated with ETV6-NTRK3 gene fusion: cytogenetic and molecular relationship to congenital (infantile) fibrosarcoma. „Am J Pathol”. 153 (5), s. 1451–1458, Nov 1998. DOI: 10.1016/S0002-9440(10)65732-X. PMID: 9811336. 
  • D.E. Schofield, J.A. Fletcher, H.E. Grier, E.J. Yunis. Fibrosarcoma in infants and children. Application of new techniques. „Am J Surg Pathol”. 18 (1), s. 14–24, Jan 1994. PMID: 8279625. 
  • I. Panagopoulos, C.T. Storlazzi, C.D. Fletcher, J.A. Fletcher i inni. The chimeric FUS/CREB3l2 gene is specific for low-grade fibromyxoid sarcoma. „Genes Chromosomes Cancer”. 40 (3), s. 218–228, Jul 2004. DOI: 10.1002/gcc.20037. PMID: 15139001. 
  • A. Matsuyama, M. Hisaoka, S. Shimajiri, T. Hayashi i inni. Molecular detection of FUS-CREB3L2 fusion transcripts in low-grade fibromyxoid sarcoma using formalin-fixed, paraffin-embedded tissue specimens. „Am J Surg Pathol”. 30 (9), s. 1077–1084, Sep 2006. DOI: 10.1097/01.pas.0000209830.24230.1f. PMID: 16931951. 
  • L. Guillou, J. Benhattar, C. Gengler, G. Gallagher i inni. Translocation-positive low-grade fibromyxoid sarcoma: clinicopathologic and molecular analysis of a series expanding the morphologic spectrum and suggesting potential relationship to sclerosing epithelioid fibrosarcoma: a study from the French Sarcoma Group. „Am J Surg Pathol”. 31 (9), s. 1387–1402, Sep 2007. DOI: 10.1097/PAS.0b013e3180321959. PMID: 17721195. 
  • S. Indap, M. Dasgupta, N. Chakrabarti, A. Agarwal. Low grade fibromyxoid sarcoma (Evans tumour) of the arm. „Indian J Plast Surg”. 47 (2), s. 259–262, May 2014. DOI: 10.4103/0970-0358.138973. PMID: 25190926. 
  • A. Kanno, M. Hatori, M. Hosaka, K.N. Kishimoto i inni. Multiple bone metastasis of sclerosing epithelioid fibrosarcoma 12 years after initial surgery-increasing ki-67 labeling index. „Sarcoma”. 2009, s. 953750, 2009. DOI: 10.1155/2009/953750. PMID: 19343182. 
  • H. Russell, M.J. Hicks, A.A. Bertuch, M. Chintagumpala. Infantile fibrosarcoma: clinical and histologic responses to cytotoxic chemotherapy. „Pediatr Blood Cancer”. 53 (1), s. 23–27, Jul 2009. DOI: 10.1002/pbc.21981. PMID: 19340853. 
  • W.S. Ferguson. Advances in the adjuvant treatment of infantile fibrosarcoma. „Expert Rev Anticancer Ther”. 3 (2), s. 185–191, Apr 2003. DOI: 10.1586/14737140.3.2.185. PMID: 12722878. 
  • D. Petrov, M. Stanoev, M. Plochev, E. Goranov i inni. Surgical treatment of pulmonary metastases-surgical methods, early and long-term results. „Khirurgiia (Sofiia)”, s. 5–10, 2008. PMID: 20063468. 
  • T.C. Mineo, V. Ambrogi, M. Paci, N. Iavicoli i inni. Transxiphoid bilateral palpation in video-assisted thoracoscopic lung metastasectomy. „Arch Surg”. 136 (7), s. 783–788, Jul 2001. PMID: 11448391. 
  • A.E. Waddell, A.M. Davis, H. Ahn, J.S. Wunder i inni. Doxorubicin-cisplatin chemotherapy for high-grade nonosteogenic sarcoma of bone. Comparison of treatment and control groups. „Can J Surg”. 42 (3), s. 190–199, Jun 1999. PMID: 10372015. 
  • Q. Bao, H. Niess, R. Djafarzadeh, Y. Zhao i inni. Recombinant TIMP-1-GPI inhibits growth of fibrosarcoma and enhances tumor sensitivity to doxorubicin. „Target Oncol”. 9 (3), s. 251–261, Sep 2014. DOI: 10.1007/s11523-013-0294-5. PMID: 23934106. 
  • M. Lehnhardt, L. Klein-Hitpass, C. Kuhnen, H.H. Homann i inni. Response rate of fibrosarcoma cells to cytotoxic drugs on the expression level correlates to the therapeutic response rate of fibrosarcomas and is mediated by regulation of apoptotic pathways. „BMC Cancer”. 5, s. 74, 2005. DOI: 10.1186/1471-2407-5-74. PMID: 16001973. 
  • V.H. Bramwell, D. Anderson, M.L. Charette. Doxorubicin-based chemotherapy for the palliative treatment of adult patients with locally advanced or metastatic soft tissue sarcoma. „Cochrane Database Syst Rev”, s. CD003293, 2003. DOI: 10.1002/14651858.CD003293. PMID: 12917960. 
  • D.J. Pritchard, F.H. Sim, J.C. Ivins, E.H. Soule i inni. Fibrosarcoma of bone and soft tissues of the trunk and extremities. „Orthop Clin North Am”. 8 (4), s. 869–881, Oct 1977. PMID: 917469. 
  • S.M. Scott, H.M. Reiman, D.J. Pritchard, D.M. Ilstrup. Soft tissue fibrosarcoma. A clinicopathologic study of 132 cases. „Cancer”. 64 (4), s. 925–931, Aug 1989. PMID: 2545330. 
  • V. Dewan, A. Darbyshire, V. Sumathi, L. Jeys i inni. Prognostic and survival factors in myxofibrosarcomas. „Sarcoma”. 2012, s. 830879, 2012. DOI: 10.1155/2012/830879. PMID: 22736953. 
  • H.L. Evans. Low-grade fibromyxoid sarcoma. A report of two metastasizing neoplasms having a deceptively benign appearance. „Am J Clin Pathol”. 88 (5), s. 615–619, Nov 1987. PMID: 3673943.